上海建工(600170.SH):振新物業已完成“民生通惠-上海建工建安1號資產支持計劃”發行
格隆匯7月25日丨上海建工(600170.SH)公佈,根據公司股東大會授權,公司全資子公司上海振新物業管理有限公司(簡稱“振新物業”)計劃發行總額不超過人民幣17.81億元資產支持類產品,並取得了中保保險資產登記交易系統有限公司出具的登記編碼ZC2025070045。上海建工為本次資產支持類產品的發行提供了增信措施,納入公司年度擔保額度。
截至2025年7月24日,振新物業已完成了“民生通惠-上海建工建安1號資產支持計劃”的發行,募集資金17.81億元已經到賬。
本次產品的發行,有助於盤活公司存量資產,進一步優化公司債務結構,降低融資成本。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.